NCT07224685 A Study of Mayo Clinic CV Research Heart & Voice Study
| NCT ID | NCT07224685 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Cardiovascular Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000,000 participants |
| Start Date | 2024-03-05 |
| Primary Completion | 2029-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000,000 participants in total. It began in 2024-03-05 with a primary completion date of 2029-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to determine whether voice recordings acquired from patient-owned Android and Apple (iOS) smartphones can be used to monitor cardiovascular health. Voice signals will be processed to determine whether we can detect presence of cardiovascular disease and wellness, or if health risks exist.
Eligibility Criteria
Inclusion Criteria: * Adult patients using the Mayo patient iPhone app and iOS 14.0 or later (determined automatically via Mayo software) and Apple Watch v 4 or later (not SE), or if they have Android device for voice * Expressed interest in participation * Signed HIPPA authorization Exclusion Criteria: • Age under 18
Contact & Investigator
Paul Friedman, M.D.
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT07224685 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07224685 currently recruiting?
Yes, NCT07224685 is actively recruiting participants. Contact the research team at priebe.amanda@mayo.edu for enrollment information.
Where is the NCT07224685 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT07224685 clinical trial?
NCT07224685 is sponsored by Mayo Clinic. The principal investigator is Paul Friedman, M.D. at Mayo Clinic. The trial plans to enroll 1,000,000 participants.